A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma
It is difficult for traditional therapies to further improve the prognosis of hepatocellular carcinoma (LIHC), and immunotherapy is considered to be a promising approach to overcome this dilemma. However, only a minority of patients benefit from immunotherapy, which greatly limits its application. T...
Saved in:
| Main Authors: | Jianlin Zhu, Junxi Kuang, Yi Yang, Lei Zhang, Bo Leng, Risheng She, Ling Zou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2023/6645476 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NSUN5 accelerates the progression of liver hepatocellular carcinoma by m5C-EFNA3-mediated glycolysis
by: Yehong Han, et al.
Published: (2025-07-01) -
NSUN5 Facilitates Hepatocellular Carcinoma Progression by Increasing SMAD3 Expression
by: Hexu Han, et al.
Published: (2025-01-01) -
Establishment and evaluation cuproptosis-related gene signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma
by: Shuo Wang, et al.
Published: (2025-04-01) -
A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma
by: Zhang Z, et al.
Published: (2025-04-01) -
and as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2017-07-01)